Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus

By Nakao K.   Hamasaki K.   Wakihama N.   Maeda M.   Ohtsubo N.   Sagiike T.   Ichikawa T.   Ishikawa H.   Eguchi K.   Ishii N.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3789-3794

Elsevier

Access to resources Recommend Favorite

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines

By Heijtink R.A.   van Bergen P.   Paulij W.P.   de Man R.A.   Osterhaus A.D.M.E.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1531-1538

Elsevier

Access to resources Recommend Favorite

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence

By Gesemann M.   Scheiermann N.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 443-447

Elsevier

Access to resources Recommend Favorite

Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years

By Da Villa G.   Peluso F.   Picciotto L.   Bencivenga M.   Elia S.   Pelliccia M.G.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1503-1505

Elsevier

Access to resources Recommend Favorite

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

By Van Herck K.   Van Damme P.   Thoelen S.   Meheus A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1933-1935

Elsevier

Access to resources Recommend Favorite